[go: up one dir, main page]

AR006283A1 - Derivados de indazol 1,3,5-trisustituidos provistos de un efecto anti- asmatico, anti-alergico, inhibidor de las inflamaciones de inmuno-modulador,procedimiento para su preparacion y su utilizacion como medicamento - Google Patents

Derivados de indazol 1,3,5-trisustituidos provistos de un efecto anti- asmatico, anti-alergico, inhibidor de las inflamaciones de inmuno-modulador,procedimiento para su preparacion y su utilizacion como medicamento

Info

Publication number
AR006283A1
AR006283A1 ARP970101088A ARP970101088A AR006283A1 AR 006283 A1 AR006283 A1 AR 006283A1 AR P970101088 A ARP970101088 A AR P970101088A AR P970101088 A ARP970101088 A AR P970101088A AR 006283 A1 AR006283 A1 AR 006283A1
Authority
AR
Argentina
Prior art keywords
asthmatic
preparation
trisustitued
inflammations
indazol
Prior art date
Application number
ARP970101088A
Other languages
English (en)
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of AR006283A1 publication Critical patent/AR006283A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen derivados de indazol 1,3,5-trisustituidos de la fórmula general (I), poseen un efecto anti-asmático, anti-alérgico, inhibidor de lasinflamaciones y/o inmunomodulador, y son adecuados para la preparación de medicamentos.
ARP970101088A 1996-03-20 1997-03-19 Derivados de indazol 1,3,5-trisustituidos provistos de un efecto anti- asmatico, anti-alergico, inhibidor de las inflamaciones de inmuno-modulador,procedimiento para su preparacion y su utilizacion como medicamento AR006283A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610882A DE19610882A1 (de) 1996-03-20 1996-03-20 Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
AR006283A1 true AR006283A1 (es) 1999-08-11

Family

ID=7788810

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970101088A AR006283A1 (es) 1996-03-20 1997-03-19 Derivados de indazol 1,3,5-trisustituidos provistos de un efecto anti- asmatico, anti-alergico, inhibidor de las inflamaciones de inmuno-modulador,procedimiento para su preparacion y su utilizacion como medicamento

Country Status (10)

Country Link
US (1) US5776932A (es)
EP (1) EP0888307A1 (es)
JP (1) JP2000506874A (es)
AR (1) AR006283A1 (es)
AU (1) AU2025697A (es)
BR (1) BR9709444A (es)
CA (1) CA2200385A1 (es)
DE (1) DE19610882A1 (es)
WO (1) WO1997034874A1 (es)
ZA (1) ZA971883B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69709493T2 (de) * 1996-06-27 2002-10-31 Pfizer Inc., New York Substituierte Indazolderivate
DE19821003A1 (de) 1998-05-11 1999-11-18 Dresden Arzneimittel Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19821002A1 (de) * 1998-05-11 1999-11-18 Dresden Arzneimittel Neue 1,5- und 3-O-substituierte 1H-Indazole mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6169185B1 (en) 1999-02-25 2001-01-02 Day-Glo Color Corp. Ink jet printing inks
DE10007203A1 (de) * 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
EP1448557A4 (en) * 2001-10-26 2005-02-02 Univ Connecticut HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
US7582631B2 (en) * 2004-01-14 2009-09-01 Amgen Inc. Substituted heterocyclic compounds and methods of use
US8034940B2 (en) 2006-08-09 2011-10-11 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2009071483A1 (en) * 2007-12-07 2009-06-11 Via Pharmaceuticals, Inc. 1- (indaz0l-5-yl) -ureas as diacylglycerol acyltransferase inhibitors
US10500178B2 (en) 2015-03-13 2019-12-10 The Board Of Trustees Of The Leland Stanford Junior University LTB4 inhibition to prevent and treat human lymphedema
CN115197117B (zh) * 2022-05-17 2023-09-15 沈阳化工大学 抑制金黄色葡萄球菌胱硫醚-γ-裂解酶的吲哚类衍生物
WO2024178219A1 (en) * 2023-02-23 2024-08-29 Brian Shoichet 1-acyl-3-aminoindazoles for treating cystic fibrosis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054833A (es) * 1963-08-09
GB1152885A (en) * 1966-08-29 1969-05-21 Acraf Indazole-3-yl-Oxyalkanoic Acids and process for the preparation thereof
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3625970A (en) * 1968-04-17 1971-12-07 Cutter Lab 1-(disubstituted phenyl or benzyl)-1h-indazol-3-yloxyacetic acid
GB1435943A (en) * 1973-02-07 1976-05-19 Delmar Chem Indazole-derived tertiary amines
US4537966A (en) * 1983-12-22 1985-08-27 Pennwalt Corporation 1-(Aminobenzoyl)-1H-indazol-3-ols
EP0191520B1 (en) * 1985-02-12 1989-06-21 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
IE910278A1 (en) * 1990-02-16 1991-08-28 Ici Plc Heterocyclic compounds
US5334597A (en) * 1991-10-17 1994-08-02 Merck Frosst Canada, Inc. Indole carbamates as leukotriene antagonists
DE4224363A1 (de) * 1992-07-23 1994-01-27 Henkel Kgaa Nitroindazolinone als Färbemittel für Fasern natürlichen Ursprungs und synthetische Fasern
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도

Also Published As

Publication number Publication date
ZA971883B (en) 1997-11-10
WO1997034874A1 (de) 1997-09-25
DE19610882A1 (de) 1997-09-25
CA2200385A1 (en) 1997-09-20
US5776932A (en) 1998-07-07
EP0888307A1 (de) 1999-01-07
AU2025697A (en) 1997-10-10
JP2000506874A (ja) 2000-06-06
BR9709444A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
AR006283A1 (es) Derivados de indazol 1,3,5-trisustituidos provistos de un efecto anti- asmatico, anti-alergico, inhibidor de las inflamaciones de inmuno-modulador,procedimiento para su preparacion y su utilizacion como medicamento
AR002039A1 (es) Pirido[3.2-e]pirazinonas con efecto antiasmatico, y procedimiento para su preparacion y los medicamentos que los contienen y su preparación
MX9700885A (es) Nuevas heteroariloxazolidinonas.
DK0873351T3 (da) Steroidnitrit/nitratesterderivater anvendelige som antiinflammatoriske lægemidler
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
WO1996023489A3 (de) Verwendung von carotinoiden zur herstellung von arzneimitteln zur behandlung von dermatosen
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
AU5485698A (en) Oxyiminopregnancarbolactone
SE9504661D0 (sv) New compounds
WO1996004266A3 (de) Indol-, indazol-, pyridopyrrol- und pyridopyrazol-derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender wirkung
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ES2193246T3 (es) Cefalosporinas antibacterianas.
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
PT1232173E (pt) Derivados do acido fusidico
DE69627184D1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften